Search results
Sen. Wyden questions Pfizer over tax rate as part of ongoing investigation
Endpoints News· 5 days agoSenate Finance Chair Ron Wyden (D-OR) is pressing Pfizer over its tax practices as part of his investigation into how large pharma companies use subsidiaries in other countries ...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
Endpoints News· 3 days agoWhen Pfizer laid out the ambitious vision for its new oncology division in February, it announced...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 3 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 4 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
Pfizer announces another $1.5B in cost cuts — and plans for more to come
Endpoints News· 4 days agoMonths after beginning a $4 billion savings strategy, Pfizer is planning on a new $1.5 billion round...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
The growing promise of cancer vaccines
Cosmos· 11 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Pfizer's $1.5B cuts; Biogen's $1.15B buyout; AstraZeneca's $80B ambition; RNA startup merger; and...
Endpoints News· 1 day agoWant this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. Whether you will be in San Diego for BIO, we hope you will join ...
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain
Motley Fool via Yahoo Finance· 3 hours agoStrong business results To be fair, quite a bit of Wells Fargo's tremendous performance occurred...